ENTITY
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

317
Analysis
Health CareChina
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
bullish3SBio Inc
22 Jul 2025 07:18

3SBio (1530 HK): Global Index Inclusion as Stock Soars

3SBio could be added to a global index in August. There is large positioning in the stock, but industry momentum could lead to further upside in...

Logo
603 Views
Share
bullishParagon REIT
11 Feb 2025 09:45

Paragon REIT (PGNREIT SP)'s Privatisation Offer

Looks pretty clean. A 7% premium to NAV and a roughly two-year high. If payment on or around late May, I'd pay up to S$0.97/share for a gross...

Logo
701 Views
Share
14 Dec 2025 06:30

Last Week In Event SPACE: National Storage, Raksul, ANE Cayman, Strategy, Broadmedia, Austal

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

Logo
323 Views
Share
14 Dec 2025 06:15

Asia-Pac M&A Weekly Wrap: Toyota Inds, Predictive Discovery, Jinke Smart Services, Meilan Airport

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
427 Views
Share
bearishANE Cayman Inc
12 Dec 2025 06:15

ANE Cayman (9956 HK): CDH Holds All The Cards

It's a binary call on CDH. Trading wide at a 5% gross spread. Given the ongoing ambiguity as to who owns what, I'm inclined to sit this one out -...

Logo
467 Views
Share
x